New partnership initiated

Published 13 July 2016

EATRIS facilitated a new partnership between IMAXIO, which is an integrated biotech company focused on vaccines ( and the Infectious Disease group of the Institute of Biomedicine of Seville (IBiS), Spain (

The initial contact with the company was initiated at the BIO USA 2014 convention in San Diego, California. The final objective of this study was to determine the efficacy of different S. aureus vaccines in a sepsis peritoneal model of infection due to S. aureus.